NCT00306176View on ClinicalTrials.gov

Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

October 31, 2006

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

Rosiglitazone

Trial Locations (1)

54454

AHEPA University Hospital of Thessaloniki, Thessaloniki

All Listed Sponsors
collaborator

University of Athens

OTHER

lead

Aristotle University Of Thessaloniki

OTHER

NCT00306176 - Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter